Lytch v. Gilead Sciences, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Lytch v. Gilead Sciences, Inc.

Sort by

Viewing results 1‒25 of 328

News in-depthPfizer Inc
Covid vaccine winners suffer reversal of fortune
...Linden Thomson, lead manager of the AXA IM Framlington Biotech fund, compared the vaccine companies with others that have had a standout year because of a single drug, such as Gilead with its hepatitis C...
October 3, 2023
Special ReportThe Americas’ Fastest Growing Companies
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
...It also paid $4.9bn this month for Alpine Immune Sciences, which is developing a treatment for an autoimmune kidney disease....
April 26, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Coronavirus treatment
WHO calls for lower prices on Gilead drug for Covid-linked black fungus
...The World Health Organization has called for prices of a Gilead Sciences drug to treat black fungus infections to be cut and supplies boosted amid a sharp rise in cases among Covid-19 patients in India and...
July 1, 2021
Coronavirus treatment
Merck struggles to win European approval for Covid antiviral pill
...“Given the current clinical outcomes data there are several therapies preferred before molnupiravir,” said Daina Graybosch, analyst at SVB Leerink, citing Paxlovid, Gilead Sciences’ remdesivir — an antiviral...
February 16, 2022
Coronavirus treatment
EU medicine regulator seeks full results of WHO’s remdesivir trial
...The European Commission announced last week that it had signed a deal with the developer, Gilead Sciences, to supply 500,000 treatment courses of the drug, worth more than €1bn....
October 16, 2020
Coronavirus treatment
Remdesivir has little effect on Covid-19 mortality, WHO study says
...It was developed by US drugmaker Gilead Sciences, initially as a potential medicine to treat Ebola....
October 16, 2020
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Coronavirus
Gilead antiviral drug remdesivir flops in first trial
...The Chinese trial showed remdesivir — developed by California-based Gilead Sciences — did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream....
April 23, 2020
Covid-19 vaccines
France cancels order for Merck antiviral tablet on efficacy fears
...France had also acted early on remdesivir, the Gilead drug whose benefit has been described as limited, restricting its use before others did....
December 22, 2021
LexCoronavirus treatment
Coronavirus pill: Merck forges a new hammer to crack pandemic Premium content
...Gilead Sciences is developing a pill version of remdesivir which, delivered intravenously, is for now the only approved antiviral against Covid....
October 12, 2021
Coronavirus treatment
Pfizer’s Covid antiviral pill slashes hospitalisation risk, trial shows
...The drug is far simpler to administer than antibody treatments or Gilead Sciences’ antiviral remdesivir, which is an infusion....
November 5, 2021
The Big Read
The Covid drugs are finally here
...So far, Gilead’s remdesivir, repurposed from a drug candidate for treating Ebola, has been the main antiviral used for Covid-19....
November 12, 2021
Gilead Sciences Inc
Gilead’s Covid drug delivers $2bn boost to revenue in Q4
...But Daniel O’Day, Gilead chief executive, said it had been widely adopted in the US....
February 4, 2021
Coronavirus treatment
Gilead secures FDA approval for remdesivir
...Daniel O’Day, chief executive, said Gilead had worked “relentlessly” to help find solutions for the pandemic....
October 22, 2020
LexGilead Sciences Inc
Gilead: no immunity Premium content
...Gilead Sciences has spent years and billions of dollars developing its oncology business....
September 14, 2020
Coronavirus treatment
Gilead insists remdesivir improves Covid-19 survival rates
...Shares in Gilead fell 1.5 per cent in after-hours trading to $57.86....
October 28, 2020
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
News in-depthCoronavirus treatment
Remdesivir: the rise and fall of a Covid wonder drug
...Remdesivir reminds some of Tamiflu, a drug co-developed by Gilead and Roche....
November 24, 2020
Coronavirus treatment
India and Pakistan ramp up remdesivir production under Gilead deal
...India and Pakistan have ramped up production of the coronavirus drug remdesivir under a licensing agreement with Gilead Sciences, but onward distribution to other developing countries has been slow.Vamsi...
September 21, 2020
Coronavirus treatment
WHO advises against prescribing remdesivir to Covid patients
...Writing in the British Medical Journal on Friday, an expert WHO panel said the drug, produced by Gilead Sciences of the US, was “not suggested for patients admitted to hospital with Covid-19, regardless...
November 20, 2020
Gilead Sciences Inc
Gilead nears deal to buy cancer drug maker for $20bn
...Gilead Sciences is close to buying Immunomedics for $20bn, as the pharmaceutical group tries to outbid rivals competing to snap up the cancer drug developer, said people briefed on the matter....
September 12, 2020
Gilead Sciences Inc
Gilead hopes to meet global remdesivir demand by October
...In the second quarter, Gilead did not meet expectations on either revenue or earnings....
July 30, 2020
LexDrug prices
Remdesivir/drug pricing: no right formula Premium content
...That would get nearer to recouping at least some of Gilead’s 2020 $1bn-plus R&D spend on the drug. Gilead’s latest estimate is for sales of 2m treatments this year....
July 2, 2020
Coronavirus treatment
Gilead says remdesivir data show reduced risk of death
...Gilead Sciences revealed more trial data on Friday showing its experimental Covid-19 drug significantly reduced the risk of death, an early sign that the antiviral treatment may go beyond just speeding up...
July 10, 2020
Coronavirus treatment
EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine
...The EMA has previously used this mechanism for Gilead’s remdesivir, the only antiviral partially approved to treat Covid-19 both in Europe and in the US....
October 6, 2020
US & Canadian companies
Regeneron halts antibody trial in seriously ill Covid patients
...Despite investment in drug trials, there are still few options for treating Covid-19, and there are concerns about how well Gilead’s remdesivir, the only antiviral that has been approved by the US regulator...
October 30, 2020
Coronavirus treatment
Gilead to charge governments $2,340 for remdesivir
...Gilead Sciences has said it will charge governments $2,340 for a 5-day course of remdesivir, a drug that has been shown to shorten the time it takes Covid-19 patients to recover....
June 29, 2020

Previous pagePage 1 of 14Next page